These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25485510)

  • 1. Cyclin A/Cdk2 regulates Cdh1 and claspin during late S/G2 phase of the cell cycle.
    Oakes V; Wang W; Harrington B; Lee WJ; Beamish H; Chia KM; Pinder A; Goto H; Inagaki M; Pavey S; Gabrielli B
    Cell Cycle; 2014; 13(20):3302-11. PubMed ID: 25485510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degrading Claspin away with Cdh1 and Cyclin A.
    Burgess A
    Cell Cycle; 2015; 14(2):171. PubMed ID: 25584742
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual regulation of the anaphase promoting complex in human cells by cyclin A-Cdk2 and cyclin A-Cdk1 complexes.
    Mitra J; Enders GH; Azizkhan-Clifford J; Lengel KL
    Cell Cycle; 2006 Mar; 5(6):661-6. PubMed ID: 16582612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.
    Huang X; Summers MK; Pham V; Lill JR; Liu J; Lee G; Kirkpatrick DS; Jackson PK; Fang G; Dixit VM
    Mol Cell; 2011 May; 42(4):511-23. PubMed ID: 21596315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression.
    Sørensen CS; Lukas C; Kramer ER; Peters JM; Bartek J; Lukas J
    Mol Cell Biol; 2001 Jun; 21(11):3692-703. PubMed ID: 11340163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A subset of cancer cell lines is acutely sensitive to the Chk1 inhibitor MK-8776 as monotherapy due to CDK2 activation in S phase.
    Sakurikar N; Thompson R; Montano R; Eastman A
    Oncotarget; 2016 Jan; 7(2):1380-94. PubMed ID: 26595527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
    Hu B; Mitra J; van den Heuvel S; Enders GH
    Mol Cell Biol; 2001 Apr; 21(8):2755-66. PubMed ID: 11283255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines.
    L'Italien L; Tanudji M; Russell L; Schebye XM
    Cell Cycle; 2006 May; 5(9):984-93. PubMed ID: 16687918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering the role of APC-Cdh1 in generating the dynamics of S-phase onset.
    Yuan X; Srividhya J; De Luca T; Lee JH; Pomerening JR
    Mol Biol Cell; 2014 Feb; 25(4):441-56. PubMed ID: 24356446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdc25-dependent activation of cyclin A/cdk2 is blocked in G2 phase arrested cells independently of ATM/ATR.
    Goldstone S; Pavey S; Forrest A; Sinnamon J; Gabrielli B
    Oncogene; 2001 Feb; 20(8):921-32. PubMed ID: 11314027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of CDC25A phosphatase is limited by CDK2/cyclin A-mediated feedback inhibition.
    Ditano JP; Sakurikar N; Eastman A
    Cell Cycle; 2021 Jul; 20(13):1308-1319. PubMed ID: 34156324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.
    De Boer L; Oakes V; Beamish H; Giles N; Stevens F; Somodevilla-Torres M; Desouza C; Gabrielli B
    Oncogene; 2008 Jul; 27(31):4261-8. PubMed ID: 18372919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear translocation of Cyclin B1 marks the restriction point for terminal cell cycle exit in G2 phase.
    Müllers E; Silva Cascales H; Jaiswal H; Saurin AT; Lindqvist A
    Cell Cycle; 2014; 13(17):2733-43. PubMed ID: 25486360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis.
    Prinz S; Hwang ES; Visintin R; Amon A
    Curr Biol; 1998 Jun; 8(13):750-60. PubMed ID: 9651679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways.
    Gao D; Inuzuka H; Korenjak M; Tseng A; Wu T; Wan L; Kirschner M; Dyson N; Wei W
    Mol Biol Cell; 2009 Jul; 20(14):3305-16. PubMed ID: 19477924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
    Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
    Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons.
    Veas-Pérez de Tudela M; Maestre C; Delgado-Esteban M; Bolaños JP; Almeida A
    Sci Rep; 2015 Dec; 5():18180. PubMed ID: 26658992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint.
    Bassermann F; Frescas D; Guardavaccaro D; Busino L; Peschiaroli A; Pagano M
    Cell; 2008 Jul; 134(2):256-67. PubMed ID: 18662541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase APC/C-Cdc20 inhibition by cyclin A2-Cdk2 ensures efficient mitotic entry.
    Hein JB; Nilsson J
    Nat Commun; 2016 Mar; 7():10975. PubMed ID: 26960431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the E3 ubiquitin ligase RNF157 as a novel downstream effector linking PI3K and MAPK signaling pathways to the cell cycle.
    Dogan T; Gnad F; Chan J; Phu L; Young A; Chen MJ; Doll S; Stokes MP; Belvin M; Friedman LS; Kirkpatrick DS; Hoeflich KP; Hatzivassiliou G
    J Biol Chem; 2017 Sep; 292(35):14311-14324. PubMed ID: 28655764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.